LOGIN
Effect of teriparatide versus alendronate or no medication on periprosethtic BMD in THA
May 2016
Effect of teriparatide versus alendronate or no medication on periprosethtic BMD in THA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Teriparatide versus alendronate for the preservation of bone mineral density after total hip arthroplasty - a randomized controlled trial
J Arthroplasty. 2016 Jan;31(1):333-8Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
48 patients scheduled for cementless total hip arthroplasty (THA) were randomized to be postoperatively administered either daily subcutaneous teriparatide, weekly oral alendronate, or no medication. The purpose of this study was to measure and compare periprosthetic bone mineral density, defined by Gruen Zones, between groups over 48 week follow-up. In addition, serum levels of procollagen type-1...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.